Literature DB >> 18038153

Mendelian randomization: can genetic epidemiology help redress the failures of observational epidemiology?

Shah Ebrahim1, George Davey Smith.   

Abstract

Establishing causal relationships between environmental exposures and common diseases is beset with problems of unresolved confounding, reverse causation and selection bias that may result in spurious inferences. Mendelian randomization, in which a functional genetic variant acts as a proxy for an environmental exposure, provides a means of overcoming these problems as the inheritance of genetic variants is independent of-that is randomized with respect to-the inheritance of other traits, according to Mendel's law of independent assortment. Examples drawn from exposures and outcomes as diverse as milk and osteoporosis, alcohol and coronary heart disease, sheep dip and farm workers' compensation neurosis, folate and neural tube defects are used to illustrate the applications of Mendelian randomization approaches in assessing potential environmental causes of disease. As with all genetic epidemiology studies there are problems associated with the need for large sample sizes, the non-replication of findings, and the lack of relevant functional genetic variants. In addition to these problems, Mendelian randomization findings may be confounded by other genetic variants in linkage disequilibrium with the variant under study, or by population stratification. Furthermore, pleiotropy of effect of a genetic variant may result in null associations, as may canalisation of genetic effects. If correctly conducted and carefully interpreted, Mendelian randomization studies can provide useful evidence to support or reject causal hypotheses linking environmental exposures to common diseases.

Entities:  

Mesh:

Year:  2007        PMID: 18038153     DOI: 10.1007/s00439-007-0448-6

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  118 in total

Review 1.  Fibrinogen, C-reactive protein and coronary heart disease: does Mendelian randomization suggest the associations are non-causal?

Authors:  G Davey Smith; R Harbord; S Ebrahim
Journal:  QJM       Date:  2004-03

2.  Hartnup disorder: unraveling the mystery.

Authors:  Jeffrey A Kraut; George Sachs
Journal:  Trends Pharmacol Sci       Date:  2005-02       Impact factor: 14.819

3.  A cautionary note on the use of Mendelian randomization to infer causation in observational epidemiology.

Authors:  Murielle Bochud; Arnaud Chiolero; Robert C Elston; Fred Paccaud
Journal:  Int J Epidemiol       Date:  2007-09-19       Impact factor: 7.196

4.  Re: Estimation of bias in nongenetic observational studies using "Mendelian triangulation" by Bautista et al.

Authors:  Duncan C Thomas; Debbie A Lawlor; John R Thompson
Journal:  Ann Epidemiol       Date:  2007-04-26       Impact factor: 3.797

5.  Fibrinogen and coronary heart disease: test of causality by 'Mendelian randomization'.

Authors:  Bernard Keavney; John Danesh; Sarah Parish; Alison Palmer; Sarah Clark; Linda Youngman; Marc Delépine; Mark Lathrop; Richard Peto; Rory Collins
Journal:  Int J Epidemiol       Date:  2006-07-26       Impact factor: 7.196

Review 6.  Familial defective apolipoprotein B-100: a review, including some comparisons with familial hypercholesterolaemia.

Authors:  N B Myant
Journal:  Atherosclerosis       Date:  1993-12       Impact factor: 5.162

7.  An integrated approach to the meta-analysis of genetic association studies using Mendelian randomization.

Authors:  Cosetta Minelli; John R Thompson; Martin D Tobin; Keith R Abrams
Journal:  Am J Epidemiol       Date:  2004-09-01       Impact factor: 4.897

8.  Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial.

Authors:  James F Toole; M René Malinow; Lloyd E Chambless; J David Spence; L Creed Pettigrew; Virginia J Howard; Elizabeth G Sides; Chin-Hua Wang; Meir Stampfer
Journal:  JAMA       Date:  2004-02-04       Impact factor: 56.272

9.  Polymorphism of alcohol and aldehyde dehydrogenase genes and alcoholic cirrhosis in Chinese patients.

Authors:  Y C Chao; S R Liou; Y Y Chung; H S Tang; C T Hsu; T K Li; S J Yin
Journal:  Hepatology       Date:  1994-02       Impact factor: 17.425

10.  Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group.

Authors:  J Shepherd; S M Cobbe; I Ford; C G Isles; A R Lorimer; P W MacFarlane; J H McKillop; C J Packard
Journal:  N Engl J Med       Date:  1995-11-16       Impact factor: 91.245

View more
  118 in total

1.  Two-step epigenetic Mendelian randomization: a strategy for establishing the causal role of epigenetic processes in pathways to disease.

Authors:  Caroline L Relton; George Davey Smith
Journal:  Int J Epidemiol       Date:  2012-02       Impact factor: 7.196

Review 2.  Genetics of lipid traits and relationship to coronary artery disease.

Authors:  Tanya E Keenan; Daniel J Rader
Journal:  Curr Cardiol Rep       Date:  2013-09       Impact factor: 2.931

Review 3.  Mendelian randomization: potential use of genetics to enable causal inferences regarding HIV-associated biomarkers and outcomes.

Authors:  Weijing He; John Castiblanco; Elizabeth A Walter; Jason F Okulicz; Sunil K Ahuja
Journal:  Curr Opin HIV AIDS       Date:  2010-11       Impact factor: 4.283

Review 4.  Prospects for epigenetic epidemiology.

Authors:  Debra L Foley; Jeffrey M Craig; Ruth Morley; Craig A Olsson; Craig J Olsson; Terence Dwyer; Katherine Smith; Richard Saffery
Journal:  Am J Epidemiol       Date:  2009-01-12       Impact factor: 4.897

Review 5.  Plasma lipoproteins: genetic influences and clinical implications.

Authors:  Robert A Hegele
Journal:  Nat Rev Genet       Date:  2009-01-13       Impact factor: 53.242

6.  Perspectives in Polycystic Ovary Syndrome: From Hair to Eternity.

Authors:  Andrea Dunaif
Journal:  J Clin Endocrinol Metab       Date:  2016-02-23       Impact factor: 5.958

7.  Instrumental variable analysis of multiplicative models with potentially invalid instruments.

Authors:  Michelle Shardell; Luigi Ferrucci
Journal:  Stat Med       Date:  2016-08-16       Impact factor: 2.373

Review 8.  Use of genetic variation as biomarkers for Alzheimer's disease.

Authors:  Christiane Reitz; Richard Mayeux
Journal:  Ann N Y Acad Sci       Date:  2009-10       Impact factor: 5.691

Review 9.  Classic and Novel Adipocytokines at the Intersection of Obesity and Cancer: Diagnostic and Therapeutic Strategies.

Authors:  Nikolaos Spyrou; Konstantinos I Avgerinos; Christos S Mantzoros; Maria Dalamaga
Journal:  Curr Obes Rep       Date:  2018-12

Review 10.  Usefulness of Mendelian randomization in observational epidemiology.

Authors:  Murielle Bochud; Valentin Rousson
Journal:  Int J Environ Res Public Health       Date:  2010-02-26       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.